Wai-ying Tsui. / Thesis (M.Ph)--Chinese University of Hong Kong. / Bibliography: leaves 164-167.

香港醫療衛生發展的論述，通常至1941年便停止，然後由1945年重新探討，跳過了二次大戰期間的日治時代。雖然有大量關於英軍回憶、遊擊隊、一些口述歷史等的研究書籍，但這時期仍未得到充分的關注，尤其在社會發展方面。本文以《香港日報》為主要材料，嘗試析述被忽略的日治醫療衛生史。 / 有關戰前香港醫療衛生的史觀，主要有「殖民醫學」與「殖民現代性」兩套理論。前者認為殖民力量將西醫強加於本地社會；後者則強調殖民統治帶來的正面作用，和殖民地有其獨特形式的現代性。直至日治前夕，香港的中西醫仍較為對等，中醫在民間有極大支持；西醫在政府政策上享有優勢。然而戰後出現的卻是另一景象，無論民間或政府皆接受西醫為主流醫學，中醫則潛藏於民間繼續傳承。這不代表中醫已被淘汰，只是西醫的發展已蓋過中醫，其中原因須追溯日治期間。日治政府承接英國殖民政府推行西醫，社會上有大量西醫常識流通，藥物使用習慣講求科學，日治時期的這些因素都為西醫在戰後普及做準備。 / 本文為過往研究所忽略作補充，藉此重新思考「日治歷史」的意義。誠然這段歷史是傷痛的，但也不可主觀地跳過而不作討論，日治時期是連接香港二戰前後的發展。醫療衛生正是其中一個脈絡，本研究將就此提出新視角。 / The analyses on Hong Kong medical and hygienic history often split into two time slots, one from the beginning as the British colony until 1941 and the other from 1945 to the present, mostly overlooking the period of Japanese occupation from 1942 to 1945. Although there are plenty of books for general readers, for examples, memoirs of British troops and Chinese guerillas, and oral history records about the Japanese occupation in Hong Kong, this period has not yet received due academic treatment. This dissertation, therefore, studies the neglected medical history of Hong Kong under the Japanese occupation using Honkon Nippō (Hong Kong News) as the main reference. / Approaches to the discussion on prewar Hong Kong medical history apparently depend on two theories, namely the “colonial medicine and the “colonial modernity. The former perspective believes that colonial powers forced colonized societies to follow the European modernity, while the latter stresses the positive effects brought by colonizers and formations of own unique modernity among colonies. Before the Japanese occupation, both traditional Chinese medicine (TCM) and Western medicine (WM) enjoyed fair status, with the TCM gaining overwhelming support from the Hong Kong society and the latter receiving administrative advantages from the colonial government. After the WWII, however, both the Hong Kong society and the government recognized the WM to be the mainstream therapy, and thus, the TCM was only praciticed at the bottom level of society without official acknowledgement. Nevertheless, this did not represent the elimination of the TCM and merely revealed the development of WM surpassing the TCM. The reason should be traced back to the period of Japanese occupation when the government sustained the policy of the British colonial government to spread the WM, causing circulation of a large amount of medical knowledge in the society and a trend of scientific drug using. All these factors benefited to the popularization of WM in Hong Kong society after WWII. / This study fills in a missing link of previous research and rethinks the implication of the “history of Japanese occupation. Indeed, the history is painful but one should not subjectively omit it because this period connected the development of Hong Kong between prewar and postwar era. This study sheds new light on medical history as well as history of Japanese occupation. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / 李威成. / "2012年8月". / "2012 nian 8 yue". / Thesis (M.Phil.)--Chinese University of Hong Kong, 2012. / Includes bibliographical references (leaves 193-201). / Abstract in Chinese and English. / Li Weicheng. / 論文摘要 --- p.i / Abstract of thesis entitled --- p.ii / 鳴謝 --- p.iii / 圖表目錄 --- p.vi / Chapter 第一章 --- 導論 --- p.1 / Chapter 第一節 --- 研究動機與目的 --- p.1 / Chapter 第二節 --- 文獻回顧 --- p.5 / Chapter 第三節 --- 研究方法 --- p.12 / Chapter 第四節 --- 論文架構 --- p.17 / Chapter 第五節 --- 研究意義 --- p.19 / Chapter 第二章 --- 戰前香港的醫療衛生發展 --- p.20 / Chapter 第一節 --- 殖民地政府的醫療衛生事業沿革 --- p.21 / Chapter 第二節 --- 民間的醫療衛生常識 --- p.29 / Chapter 第三節 --- 戰前香港醫療衛生與日本人 --- p.37 / Chapter 第四節 --- 《香港日報》的創辦與發展 --- p.43 / Chapter 第五節 --- 小結 --- p.49 / Chapter 第三章 --- 日治香港政府的醫療衛生概觀 --- p.51 / Chapter 第一節 --- 日治政府醫療管理與醫生註冊 --- p.52 / Chapter 第二節 --- 疾病控制與防疫運動 --- p.67 / Chapter 第三節 --- 環境衛生與糞便處理 --- p.76 / Chapter 第四節 --- 區制、戶籍登記與醫療衛生制度 --- p.87 / Chapter 第五節 --- 小結 --- p.97 / Chapter 第四章 --- 從《香港日報》看日治時期醫療衛生常識的傳播 --- p.99 / Chapter 第一節 --- 副刊專欄與醫藥新知 --- p.100 / Chapter 第二節 --- 公共衛生資訊的提供 --- p.116 / Chapter 第三節 --- 小結 --- p.133 / Chapter 第五章 --- 從《香港日報》看日治時期治療藥物的供應 --- p.135 / Chapter 第一節 --- 《香港日報》中的藥物廣告 --- p.136 / Chapter 第二節 --- 流通市面的藥物 --- p.155 / Chapter 第三節 --- 贈醫所及個人醫師的角色 --- p.165 / Chapter 第四節 --- 小結 --- p.173 / Chapter 第六章 --- 總結日治時期的影響──香港醫療的延續與前進 --- p.175 / Chapter 第一節 --- 醫療體制的過渡 --- p.175 / Chapter 第二節 --- 從日治醫療史看日治歷史性質 --- p.187 / Chapter 附錄(一) --- 日治期間各分區新舊名稱轉換、區長副區長及區會員數目表列 --- p.191 / Chapter 附錄(二) --- 香督令第二十一號(1942年)[節錄] --- p.192 / Chapter 附錄(三) --- 香督令第十六號(1944年) --- p.193 / 參考書目 --- p.194

Kuok, Chiu Fai. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2009. / Includes bibliographical references (leaves 139-154). / Abstract and appendix also in Chinese. / Abstract --- p.i / Abstract (in Chinese) --- p.iv / Acknowledgements --- p.vi / Table of Contents --- p.vii / List of Tables --- p.xi / List of Figures --- p.xiv / List of Abbreviations --- p.xv / Chapter Chapter 1 --- Introduction / Chapter 1.1 --- Introduction --- p.1 / Chapter 1.2 --- The Impact of Malignant Diseases and Multiple Myeloma --- p.4 / Chapter 1.3 --- Pharmacoeconomics --- p.6 / Chapter 1.4 --- Macao Healthcare System --- p.9 / Chapter 1.5 --- Study Hypothesis --- p.12 / Chapter 1.6 --- Study Objectives --- p.12 / Chapter 1.7 --- Perspective of the Study --- p.13 / Chapter Chapter 2 --- Literature Review / Chapter 2.1 --- Hematopoietic System --- p.14 / Chapter 2.1.1 --- Specific Blood Cell Lineages and Blood Cells --- p.15 / Chapter 2.1.2 --- Bone Marrow Microenvironment --- p.19 / Chapter 2.2 --- The Hematologic Malignancies --- p.20 / Chapter 2.2.1 --- Leukemia --- p.21 / Chapter 2.2.2 --- Lymphoma --- p.23 / Chapter 2.2.3 --- Plasma Cell Disorders --- p.24 / Chapter 2.3 --- Multiple Myeloma --- p.25 / Chapter 2.3.1 --- Epidemiology --- p.26 / Chapter 2.3.2 --- Pathology --- p.29 / Chapter 2.3.3 --- Clinical Presentation and Disease Complications --- p.31 / Chapter 2.3.4 --- Classification and Diagnostic Criteria --- p.35 / Chapter 2.3.5 --- Disease Staging and Prognosis --- p.42 / Chapter 2.3.6 --- Treatment --- p.45 / Chapter 2.3.6.1 --- Treatment Regimens and Strategies --- p.47 / Chapter 2.3.6.1.1 --- Standard Chemotherapy --- p.48 / Chapter 2.3.6.1.1.1 --- Melphalan-based Regimens --- p.51 / Chapter 2.3.6.1.1.2 --- VAD-based Regimens --- p.52 / Chapter 2.3.6.1.1.3 --- High-dose Glucocorticoid Regimens --- p.53 / Chapter 2.3.6.1.2 --- Treatment Strategies --- p.53 / Chapter 2.3.6.1.2.1 --- Initial Chemotherapy --- p.53 / Chapter 2.3.6.1.2.2 --- High-dose Chemotherapy --- p.55 / Chapter 2.3.6.1.2.3 --- Newer Therapeutic Agents for Multiple Myeloma --- p.58 / Chapter 2.3.6.1.2.4 --- Salvage Chemotherapy --- p.60 / Chapter 2.3.6.2 --- Treatment Responses --- p.63 / Chapter 2.3.6.3 --- Treatment for Disease Complications --- p.66 / Chapter Chapter 3 --- Methodology / Chapter 3.1 --- Study Design --- p.69 / Chapter 3.2 --- Patients Selection Criteria --- p.71 / Chapter 3.2.1 --- For Retrospective Cost Analysis --- p.71 / Chapter 3.2.2 --- For Health-related Quality of Life Measurement --- p.71 / Chapter 3.3 --- Patient Screening --- p.72 / Chapter 3.4 --- Data Collection --- p.72 / Chapter 3.5 --- Overview of Assessment Methods --- p.73 / Chapter 3.5.1 --- Outcomes --- p.73 / Chapter 3.5.2 --- Cost Analysis --- p.74 / Chapter 3.5.3 --- Cost Effectiveness Analysis --- p.74 / Chapter 3.5.4 --- Cost Utility Analysis --- p.75 / Chapter 3.5.5 --- Health-related Quality of Life Assessment --- p.75 / Chapter 3.6 --- Statistical Analysis --- p.76 / Chapter 3.7 --- Ethic approval --- p.77 / Chapter Chapter 4 --- Results / Chapter 4.1 --- Study Population --- p.78 / Chapter 4.1.1 --- Cost and Pharmacoeconomic Analysis --- p.78 / Chapter 4.1.2 --- Health-related Quality of Life Assessment --- p.79 / Chapter 4.2 --- Study Results --- p.81 / Chapter 4.2.1 --- Comparison of All Patients --- p.81 / Chapter 4.2.1.1 --- Differences in Treatment Protocols --- p.81 / Chapter 4.2.1.2 --- Differences in Treatment Responses --- p.82 / Chapter 4.2.1.3 --- Differences in Treatment Outcomes --- p.82 / Chapter 4.2.1.4 --- Differences in Treatment Costs --- p.84 / Chapter 4.2.2 --- Comparison for Patients Treated by Melphalan-based Regimens and VAD-based Regimens --- p.90 / Chapter 4.2.2.1 --- Differences in Treatment Responses --- p.90 / Chapter 4.2.2.2 --- Differences in Treatment Outcomes --- p.90 / Chapter 4.2.2.3 --- Differences in Treatment Costs --- p.93 / Chapter 4.2.3 --- Melphalan-based Regimens Versus VAD-based Regimens by Patients with Different DS Staging --- p.96 / Chapter 4.2.3.1 --- Patients in Stage 3-A MM --- p.96 / Chapter 4.2.3.2 --- Patients in Stage 3-B MM --- p.98 / Chapter 4.2.4 --- Melphalan-based Regimens versus VAD-based Regimens in Patients with Different IS Staging --- p.101 / Chapter 4.2.4.1 --- Patients in Stage I MM --- p.101 / Chapter 4.2.4.2 --- Patients in Stage II MM --- p.104 / Chapter 4.2.4.3 --- Patients in Stage III MM --- p.107 / Chapter 4.2.5 --- Comparison for Patients with and without Transplantation --- p.110 / Chapter 4.2.6 --- Cost-effectiveness Assessment --- p.117 / Chapter 4.2.7 --- Cost-utility Assessment --- p.118 / Chapter 4.2.8 --- Sensitivity Analysis --- p.119 / Chapter 4.2.9 --- Health-related Quality of Life Assessment --- p.120 / Chapter Chapter 5 --- Discussion and Conclusion / Chapter 5.1 --- Summary of Results --- p.123 / Chapter 5.2 --- Implication for Treatment --- p.126 / Chapter 5.3 --- Economic Evaluation --- p.129 / Chapter 5.4 --- Health-related Quality of Life --- p.132 / Chapter 5.5 --- Limitations of the Study --- p.134 / Chapter 5.6 --- Conclusion and Implications for Future Studies --- p.135 / Appendix --- p.137 / References --- p.139

University of Macau / Institute of Chinese Medical Sciences

published_or_final_version / Nursing Studies / Master / Master of Nursing in Advanced Practice

Background: As in the rest of the world, cancer has been a leading killer in Hong Kong. Though technology has been growing rapidly, expensive cancer treatments have continuously been problematic to patients and their families. There are some known risk factors that make some people have a higher risk for cancer than others, but the reason why some develop cancer and some do not is mostly still unknown. In addition, the expensive cancer treatments can distress patients and their families psychologically during the painful and long chemotherapy process which is a common cancer treatment. While it is important for experts to research on effective cancer treatment, it is also important for the government and health care experts to solve associated financial problems. In response to help patients to ease their financial burden of expensive medical treatment, the Hong Kong government has proposed a new health protection scheme (HPS), “My Health, My Choice.” Objective: In this paper, a systematic review on different published literatures is conducted to analyze the prospective outcome of HPS and if it can help patients to ease their financial burden. Results and Discussion: The Health scheme provides a financial aid option for patients who suffer from chemotherapy through monthly premium. However, the implementation of this HPS seems to be difficult both on the patients’ and the providers’ sides. Case study of health care systems in US and Canada is included in this paper to find out what Hong Kong can learn from other countries with completely different payment systems would manage to deal with this problem. Australia which with a universal coverage health care system has also proposed a similar HPS plan aiming to help lower health care cost by increasing individual responsibility on medical expenses. However, it failed by lack of support from the general public. The Australian example would be used to criticize some essential elements that would contribute to the failure of the HPS, and how Hong Kong would use this example to yield a better proposal. Conclusion: As HPS might not be able to ease the burden on cancer patients in Hong Kong, it is suggested for government to allocate more effective and direct resources on helping cancer patients, especially those who are receiving chemotherapy or improve services through better primary care. However, the final outcome remains unknown, and the final option still depends on the ultimate need from the general public. / published_or_final_version / Public Health / Master / Master of Public Health

published_or_final_version / Medical Sciences / Master / Master of Medical Sciences

published_or_final_version / Medical Sciences / Master / Master of Medical Sciences

University of Macau / Faculty of Social Sciences. / Department of Government and Public Administration

Finally, through the application of spatial analytical and spatial statistical methods, a better understanding of the spatial patterns of TCM and Western medical services and their correlations with urban morphology, market, religious, educational and legal patterns can be acquired. / First, Republican Beijing historical information management can successfully manage integrated data for medical service studies of Republican Beijing. Historical data coming out of the historical enquiries can be collected, organized, managed, processed, analyzed and displayed. This framework may have some methodological implications on how to collect, organize, represent and analyze historical urban information in a GIS environment. / Second, Republican Beijing historical GIS database is not just the foundation of spatial analysis in this research, but provides a useful resource for scholars in many years to come. Through this database, public health, urban morphology, education, religion, market and legal cultural observations can be accessed by any investigator throughout Republican Beijing. The approach to identifying the street number improves the accuracy of the database while the approach of zoning 80 districts solves the Modifiable Areal Unit Problem. In fact, these are very common problems encountered in historical GIS research that are concerned with "accuracy" and "scale". The two approaches may shed some light on solving such problems. / This research applies an historical GIS approach, which focuses on the spatial dimension as well as quantitative analysis to explore aspects of TCM and Western medical services in Beijing from 1912 to 1937. This dissertation provides a framework for successful integrated data management by establishing Republican Beijing historical information management as an organizational priority. Based on this framework, a system that integrates the functions of data storage, selective retrieval, analysis, display and archiving is established. First, Republican Beijing historical GIS database is produced. Two approaches are provided to work out the street number sequences and zone the 80 subdistricts respectively. Second, four kinds of spatial analytical methods, including buffer analysis, two-step floating catchment area method, spatial auto-correlation and GWR are integrated and used to explore the spatial patterns of TCM, Western medical services and their correlations with urban morphology, market, religious, educational and legal patterns. The main contributions are three-fold: / Zhang, Peiyao. / Advisers: Lin Hui; Billy K. L. So. / Source: Dissertation Abstracts International, Volume: 73-01, Section: A, page: . / Thesis (Ph.D.)--Chinese University of Hong Kong, 2010. / Includes bibliographical references (leaves 150-163). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. [Ann Arbor, MI] : ProQuest Information and Learning, [201-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstract also in Chinese.